Cleared Traditional

MUREX RUB-EX

K954920 · Murex Diagnostics, Inc. · Microbiology
Aug 1996
Decision
300d
Days
Class 2
Risk

About This 510(k) Submission

K954920 is an FDA 510(k) clearance for the MUREX RUB-EX, a Latex Agglutination Assay, Rubella (Class II — Special Controls, product code LQN), submitted by Murex Diagnostics, Inc. (Norcross, US). The FDA issued a Cleared decision on August 21, 1996, 300 days after receiving the submission on October 26, 1995. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3510.

Submission Details

510(k) Number K954920 FDA.gov
FDA Decision Cleared SESE
Date Received October 26, 1995
Decision Date August 21, 1996
Days to Decision 300 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LQN — Latex Agglutination Assay, Rubella
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3510

Similar Devices — LQN Latex Agglutination Assay, Rubella

All 12
RUBELLACOL
K031490 · Immunostics Inc., · Jul 2003
COPALIS TORC TOTAL ANTIBODY ASSAY
K970931 · Sienna Biotech, Inc. · Apr 1997
COPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY ASSAYS
K961784 · Sienna Biotech, Inc. · Oct 1996
COLORSLIDER RUBELLA
K952544 · Seradyn, Inc. · Jan 1996
RUBALEX, MODIFICATION
K912391 · Orion Corp. · May 1992
RESUBMITTED MODIFIED RUBALEX
K901637 · Orion Corp. · Apr 1990